Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Dzharullaeva, A. S., Tukhvatulina, N. M., Shcheblyakov, D. V., . . . Gintsburg, A. L. (2017). Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. Hum Vaccin Immunother.
Chicago Style CitationDolzhikova, I. V., et al. "Safety and Immunogenicity of GamEvac-Combi, a Heterologous VSV- and Ad5-vectored Ebola Vaccine: An Open Phase I/II Trial in Healthy Adults in Russia." Hum Vaccin Immunother 2017.
MLA CitationDolzhikova, I. V., et al. "Safety and Immunogenicity of GamEvac-Combi, a Heterologous VSV- and Ad5-vectored Ebola Vaccine: An Open Phase I/II Trial in Healthy Adults in Russia." Hum Vaccin Immunother 2017.